Editorial
 THE US SHOCKER   
 Wednesday, May 22, 2019 
 The action of 40 states of the US in filing a lawsuit accusing 20 top pharmaceutical companies including 7 Indian companies for conspiring to inflate prices of 100 commonly used medicines last week is not totally unexpected. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]AveXis's gene therapy Zolgensma receives US FDA approval to treat paediatric patients with SMA
17:00  [IST]Teva Pharma to pay US$ 85 million to State of Oklahoma to resolve opioids case
16:10  [IST]Unichem Labs' standalone net jumps by 342% in Q4, dividend of 200%
16:00  [IST]Pfizer's phase 3 trial of Lyrica in primary generalized tonic- clonic seizures fails to meet primary endpoint
15:30  [IST]RIL to acquire Bengaluru- based software provider company C-Square Info Solutions
15:20  [IST]BGS Gleneagles Global Hospital starts a community initiative for little kids - ‘Namma Little Doctors’
more news >>
TOP NEWS
08:00  [IST]Maharashtra govt amends IPC Rules to make illegal trading of medicines a non-bailable offence
08:00  [IST]Karnataka DC dept links 12 Sakala services to Seva Sindhu portal to ensure time- bound access to pharma service certificates
08:00  [IST]Demand for pharmacy courses on the rise in India, Telangana to witness 30% increase in demand: AICTE report
08:00  [IST]GSPC suspends registrations of 5 pharmacists in Gujarat for renting out certificates to retail pharmacies
08:00  [IST]Healthcare organizations witness escalation of risks in cybersecurity: Arvind Srinivasan
08:00  [IST]Ayush ministry launches panchkarma assistant training course to tide over shortage of technical staff
more news >>
YESTERDAY'S NEWS
18:00  [IST]THINK Surgical seeks US FDA marketing approval for its active robot, TSolution One for use in total knee replacement procedures
17:00  [IST]Bayer inks 5-year partnership with WFH Humanitarian Aid Program
16:00  [IST]Angels Initiative creates network of 1,500 stroke-ready clinics across Europe
15:00  [IST]Study shows incidence rates of aggressive subtypes of uterine cancer rising
14:00  [IST]Alverno Labs goes digital with Philips to innovate pathology services
13:00  [IST]ProBioGen, Abcuro ink GlymaxX-improved cell line development & GMP production agreement
more news >>
INTERVIEW  
Advanced flooring, integral part of pharma & healthcare infrastructure
Agradeep Mondal, Director Sales, Interface South Asia115398Agradeep
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
CP: HI_Korea_2019_150x60
IPJ_2019_pharmabiz_150x60
Ipe_2019_150x 60
CPhI_Korea_2019_150x60
PharmaLytica150x60_2019
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |